# Pilot Study of Raptiva to Treat Sjogren's Syndrome

> **NCT00344448** · PHASE2 · TERMINATED · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 10 (actual)

## Conditions studied

- Sjogren's Syndrome

## Interventions

- **DRUG:** Raptiva

## Key facts

- **NCT ID:** NCT00344448
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Increased risk of PML associated with raptiva in other studies
- **Last updated:** 2015-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00344448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00344448, "Pilot Study of Raptiva to Treat Sjogren's Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00344448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*